체외진단 품질 관리 시장 점유율, 규모, 동향, 산업 분석 보고서 : 제품 및 서비스별, 기술별, 제조업체 유형별, 최종사용자별, 지역별, 부문별 예측(2024-2032년)

The global in vitro diagnostics quality control market size is expected to reach USD 1.87 billion by 2032, according to a new study by Polaris Market Research. The report "In Vitro Diagnostics Quality Control Market Share, Size, Trends, Industry Analysis Report - By Product & Services, Technology, Manufacturing Type, End User, and Region; Segment Forecast, 2019-2032" gives a detailed insight into the current market dynamics and provides analysis on future market growth.

The increasing demand for in vitro diagnostic (IVD) quality control solutions is driven by the rising healthcare needs of aging populations and the surging prevalence of chronic conditions such as diabetes and cardiovascular diseases. Healthcare systems are under pressure to ensure the accuracy and reliability of diagnostic tests, leading to a high focus on quality control in IVD testing. Strict quality control in IVD helps maintain consistency of diagnostic results, minimize errors, and ensure effective treatments.

In April 2024, the US Food and Drug Administration announced its assistance for developing higher-performing laboratory-manufactured tests by amending IVD devices within the Federal Food, Drug, and Cosmetic Act (FD&C Act), particularly when the producer of these tools is a laboratory.

The increasing use of healthcare devices to monitor patients' conditions and provide effective treatments is driving the production of devices such as diagnostic test kits, medical imaging devices, POC diagnostic devices, and others, which creates a strong demand for quality control systems to ensure compliance with government standards. Additionally, the growing innovations from major market players are expected to boost market growth during the forecast period. In January 2024, ELITechGroup launched the GI Bacterial PLUS ELITe MGB Kit, an advanced diagnostic tool targeting major bacterial pathogens responsible for gastrointestinal infections. The CE-IVDR-certified kit is fully validated with their sample-to-result instruments. The company announced its plans to release three additional kits in the future, covering parasitic and viral pathogens, to offer a comprehensive diagnostic solution for gastrointestinal infections.

In Vitro Diagnostics Quality Control Market Report Highlights

The quality control products segment is expected to experience the highest growth during the forecast period, driven by increasing government policies promoting the availability of safety tools.

The third-party control segment dominates the IVD quality control market due to a wide range of diagnostic instruments from various manufacturers, providing flexibility and compatibility for laboratories using different types of analyzers.

In 2023, North America held the largest share of the in vitro diagnostics quality control market due to its highly developed healthcare infrastructure, which includes numerous hospitals, clinical laboratories, and research institutions.

The APAC market is expected to experience the fastest growth during the forecast period due to the increasing expansion activities of market players.

A few global players include Abbott Laboratories; Alpha-Tec Systems; Bio-Rad Laboratories; Bio-Techne Danaher; Fortress Diagnostics; and Grifols.

Polaris Market Research has segmented the in vitro diagnostics quality control market report on the basis of product & services, technology, manufacturing type, end user, and region:

By Product & Service Outlook (Revenue - USD Billion, 2019-2032)

• Quality Control Products
• Serum/ Plasma Based Controls
• Whole Blood Based Controls
• Urine Based Controls
• Other Controls
• Data Management Solutions
• Quality Assurance Services

By Technology Outlook (Revenue - USD Billion, 2019-2032)

• Immunochemistry
• Clinical Chemistry
• Molecular Diagnostics
• Microbiology
• Hematology
• Coagulation/ Hemostasis
• Other Technologies

By Manufacturing Type Outlook (Revenue - USD Billion, 2019-2032)

• Third-Party Controls
• Independent Controls
• Instrument Specific Controls
• Original Equipment Manufacturer Controls

By End User Outlook (Revenue - USD Billion, 2019-2032)

• Hospitals
• Clinical Laboratories
• Academic and Research Institutes
• Other End Users

By Regional Outlook (Revenue - USD Billion, 2019-2032)

• North America
• US
• Canada
• Europe
• Germany
• UK
• France
• Italy
• Spain
• Russia
• Netherlands
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Malaysia
• Latin America
• Argentina
• Brazil
• Mexico
• Middle East & Africa
• UAE
• Saudi Arabia
• Israel
• South Africa

Table of Contents

1. Introduction

• 1.1. Report Description
  • 1.1.1. Objectives of the Study
  • 1.1.2. Market Scope
  • 1.1.3. Assumptions
• 1.2. Stakeholders

2. Executive Summary

• 2.1. Market Highlights

3. Research Methodology

• 3.1. Overview
  • 3.1.1. Data Mining
• 3.2. Data Sources
  • 3.2.1. Primary Sources
  • 3.2.2. Secondary Sources

4. In Vitro diagnostics quality control Market Insights

• 4.1. In Vitro diagnostics quality control- Application Snapshot
• 4.2. In Vitro diagnostics quality control Dynamics
  • 4.2.1. Drivers and Opportunities
    • 4.2.1.1. Rising Prevalence of Chronic Conditions and Infectious Diseases
    • 4.2.1.2. Increasing Technological Advancements in Diagnostic
  • 4.2.2. Restraints and Challenges
    • 4.2.2.1. Unfavourable Reimbursement Scenario for IVD Tests
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers (Moderate)
  • 4.3.2. Threats of New Entrants: (Low)
  • 4.3.3. Bargaining Power of Buyers (Moderate)
  • 4.3.4. Threat of Substitute (Moderate)
  • 4.3.5. Rivalry among existing firms (High)
• 4.4. PESTEL Analysis
• 4.5. In Vitro diagnostics quality control Application Trends
• 4.6. Value Chain Analysis

5. In Vitro diagnostics quality control Market, by Product and Service

• 5.1. Key Findings
• 5.2. Introduction
  • 5.2.1. In Vitro diagnostics quality control Market, by Product and Service, 2019-2032 (USD billion)
• 5.3. Quality control products
  • 5.3.1. In Vitro diagnostics quality control Market, by Quality control products, by Region, 2019-2032 (USD billion)
• 5.4. Data Management Solutions
  • 5.4.1. In Vitro diagnostics quality control Market, by Data Management Solutions, by Region, 2019-2032 (USD billion)
• 5.5. Quality Assurance Services
  • 5.5.1. In Vitro diagnostics quality control Market, by Quality Assurance Services, by Region, 2019-2032 (USD billion)

6. In Vitro diagnostics quality control Market, by Technology

• 6.1. Key Findings
• 6.2. Introduction
  • 6.2.1. In Vitro diagnostics quality control Market, by Technology, 2019-2032 (USD billion)
• 6.3. Immunochemistry
  • 6.3.1. In Vitro diagnostics quality control Market, Immunochemistry, by Region, 2019-2032 (USD billion)
• 6.4. Clinical Chemistry
  • 6.4.1. In Vitro diagnostics quality control Market, by Clinical Chemistry, by Region, 2019-2032 (USD billion)
• 6.5. Molecular Diagnostics
  • 6.5.1. In Vitro diagnostics quality control Market, by Molecular Diagnostics, by Region, 2019-2032 (USD billion)
• 6.6. Microbiology
  • 6.6.1. In Vitro diagnostics quality control Market, by Microbiology, by Region, 2019-2032 (USD billion)
• 6.7. Hematology
  • 6.7.1. In Vitro diagnostics quality control Market, by Hematology, by Region, 2019-2032 (USD billion)
• 6.8. Coagulation/Hemostasis
  • 6.8.1. In Vitro diagnostics quality control Market, by Coagulation/Hemostasis, by Region, 2019-2032 (USD billion)
• 6.9. Other Technologies
  • 6.9.1. In Vitro diagnostics quality control Market, by Other Technologies, by Region, 2019-2032 (USD billion)

7. In Vitro diagnostics quality control Market, by Manufacturer Type

• 7.1. Key Findings
• 7.2. Introduction
  • 7.2.1. In Vitro diagnostics quality control Market, by Manufacturer Type, 2019-2032 (USD billion)
• 7.3. Third-party controls
  • 7.3.1. In Vitro diagnostics quality control Market, by Third-party controls, by Region, 2019-2032 (USD billion)
• 7.4. Original Equipment Manufacturer controls
  • 7.4.1. In Vitro diagnostics quality control Market, by Original Equipment Manufacturer controls, by Region, 2019-2032 (USD billion)

8. In Vitro diagnostics quality control Market, by End User

• 8.1. Key Findings
• 8.2. Introduction
  • 8.2.1. In Vitro diagnostics quality control Market, by End User, 2019-2032 (USD billion)
• 8.3. Hospitals
  • 8.3.1. In Vitro diagnostics quality control Market, by Hospitals, by Region, 2019-2032 (USD billion)
• 8.4. Clinical Laboratories
  • 8.4.1. In Vitro diagnostics quality control Market, by Clinical Laboratories, by Region, 2019-2032 (USD billion)
• 8.5. Academic and Research Institutes
  • 8.5.1. In Vitro diagnostics quality control Market, by Academic and Research Institutes, by Region, 2019-2032 (USD billion)
• 8.6. Other End User
  • 8.6.1. In Vitro diagnostics quality control Market, by Other End User, by Region, 2019-2032 (USD billion)

9. In Vitro diagnostics quality control Market, by Geography

• 9.1. Key Findings
• 9.2. Introduction
  • 9.2.1. In Vitro diagnostics quality control Assessment, By Geography, 2019-2032 (USD billion)
• 9.3. In Vitro diagnostics quality control- North America
  • 9.3.1. North America: In Vitro diagnostics quality control, by Product and Service, 2019-2032 (USD billion)
  • 9.3.2. North America: In Vitro diagnostics quality control, by Technology, 2019-2032 (USD billion)
  • 9.3.3. North America: In Vitro diagnostics quality control, by Manufacturer Type, 2019-2032 (USD billion)
  • 9.3.4. North America: In Vitro diagnostics quality control, by End User, 2019-2032 (USD billion)
  • 9.3.5. In Vitro diagnostics quality control- U.S.
    • 9.3.5.1. U.S.: In Vitro diagnostics quality control, by Product and Service, 2019-2032 (USD billion)
    • 9.3.5.2. U.S.: In Vitro diagnostics quality control, by Technology, 2019-2032 (USD billion)
    • 9.3.5.3. U.S.: In Vitro diagnostics quality control, by Manufacturer Type, 2019-2032 (USD billion)
    • 9.3.5.4. U.S.: In Vitro diagnostics quality control, by End User, 2019-2032 (USD billion)
  • 9.3.6. In Vitro diagnostics quality control- Canada
    • 9.3.6.1. Canada: In Vitro diagnostics quality control, by Product and Service, 2019-2032 (USD billion)
    • 9.3.6.2. Canada: In Vitro diagnostics quality control, by Technology, 2019-2032 (USD billion)
    • 9.3.6.3. Canada: In Vitro diagnostics quality control, by Manufacturer Type, 2019-2032 (USD billion)
    • 9.3.6.4. Canada: In Vitro diagnostics quality control, by End User, 2019-2032 (USD billion)
• 9.4. In Vitro diagnostics quality control- Europe
  • 9.4.1. Europe: In Vitro diagnostics quality control, by Product and Service, 2019-2032 (USD billion)
  • 9.4.2. Europe: In Vitro diagnostics quality control, by Technology, 2019-2032 (USD billion)
  • 9.4.3. Europe: In Vitro diagnostics quality control, by Manufacturer Type, 2019-2032 (USD billion)
  • 9.4.4. Europe: In Vitro diagnostics quality control, by End User, 2019-2032 (USD billion)
  • 9.4.5. In Vitro diagnostics quality control- UK
    • 9.4.5.1. UK: In Vitro diagnostics quality control, by Product and Service, 2019-2032 (USD billion)
    • 9.4.5.2. UK: In Vitro diagnostics quality control, by Technology, 2019-2032 (USD billion)
    • 9.4.5.3. UK: In Vitro diagnostics quality control, by Manufacturer Type, 2019-2032 (USD billion)
    • 9.4.5.4. UK: In Vitro diagnostics quality control, by End User, 2019-2032 (USD billion)
  • 9.4.6. In Vitro diagnostics quality control- France
    • 9.4.6.1. France: In Vitro diagnostics quality control, by Product and Service, 2019-2032 (USD billion)
    • 9.4.6.2. France: In Vitro diagnostics quality control, by Technology, 2019-2032 (USD billion)
    • 9.4.6.3. France: In Vitro diagnostics quality control, by Manufacturer Type, 2019-2032 (USD billion)
    • 9.4.6.4. France: In Vitro diagnostics quality control, by End User, 2019-2032 (USD billion)
  • 9.4.7. In Vitro diagnostics quality control- Germany
    • 9.4.7.1. Germany: In Vitro diagnostics quality control, by Product and Service, 2019-2032 (USD billion)
    • 9.4.7.2. Germany: In Vitro diagnostics quality control, by Technology, 2019-2032 (USD billion)
    • 9.4.7.3. Germany: In Vitro diagnostics quality control, by Manufacturer Type, 2019-2032 (USD billion)
    • 9.4.7.4. Germany: In Vitro diagnostics quality control, by End User, 2019-2032 (USD billion)
  • 9.4.8. In Vitro diagnostics quality control- Italy
    • 9.4.8.1. Italy: In Vitro diagnostics quality control, by Product and Service, 2019-2032 (USD billion)
    • 9.4.8.2. Italy: In Vitro diagnostics quality control, by Technology, 2019-2032 (USD billion)
    • 9.4.8.3. Italy: In Vitro diagnostics quality control, by Manufacturer Type, 2019-2032 (USD billion)
    • 9.4.8.4. Italy: In Vitro diagnostics quality control, by End User, 2019-2032 (USD billion)
  • 9.4.9. In Vitro diagnostics quality control- Spain
    • 9.4.9.1. Spain: In Vitro diagnostics quality control, by Product and Service, 2019-2032 (USD billion)
    • 9.4.9.2. Spain: In Vitro diagnostics quality control, by Technology, 2019-2032 (USD billion)
    • 9.4.9.3. Spain: In Vitro diagnostics quality control, by Manufacturer Type, 2019-2032 (USD billion)
    • 9.4.9.4. Spain: In Vitro diagnostics quality control, by End User, 2019-2032 (USD billion)
  • 9.4.10. In Vitro diagnostics quality control- Netherlands
    • 9.4.10.1. Netherlands: In Vitro diagnostics quality control, by Product and Service, 2019-2032 (USD billion)
    • 9.4.10.2. Netherlands: In Vitro diagnostics quality control, by Technology, 2019-2032 (USD billion)
    • 9.4.10.3. Netherlands: In Vitro diagnostics quality control, by Manufacturer Type, 2019-2032 (USD billion)
    • 9.4.10.4. Netherlands: In Vitro diagnostics quality control, by End User, 2019-2032 (USD billion)
  • 9.4.11. In Vitro diagnostics quality control- Russia
    • 9.4.11.1. Russia: In Vitro diagnostics quality control, by Product and Service, 2019-2032 (USD billion)
    • 9.4.11.2. Russia: In Vitro diagnostics quality control, by Technology, 2019-2032 (USD billion)
    • 9.4.11.3. Russia: In Vitro diagnostics quality control, by Manufacturer Type, 2019-2032 (USD billion)
    • 9.4.11.4. Russia: In Vitro diagnostics quality control, by End User, 2019-2032 (USD billion)
  • 9.4.12. In Vitro diagnostics quality control- Rest of Europe
    • 9.4.12.1. Rest of Europe: In Vitro diagnostics quality control, by Product and Service, 2019-2032 (USD billion)
    • 9.4.12.2. Rest of Europe: In Vitro diagnostics quality control, by Technology, 2019-2032 (USD billion)
    • 9.4.12.3. Rest of Europe: In Vitro diagnostics quality control, by Manufacturer Type, 2019-2032 (USD billion)
    • 9.4.12.4. Rest of Europe: In Vitro diagnostics quality control, by End User, 2019-2032 (USD billion)
• 9.5. In Vitro diagnostics quality control- Asia Pacific
  • 9.5.1. Asia Pacific: In Vitro diagnostics quality control, by Product and Service, 2019-2032 (USD billion)
  • 9.5.2. Asia Pacific: In Vitro diagnostics quality control, by Technology, 2019-2032 (USD billion)
  • 9.5.3. Asia Pacific: In Vitro diagnostics quality control, by Manufacturer Type, 2019-2032 (USD billion)
  • 9.5.4. Asia Pacific: In Vitro diagnostics quality control, by End User, 2019-2032 (USD billion)
  • 9.5.5. In Vitro diagnostics quality control- China
    • 9.5.5.1. China: In Vitro diagnostics quality control, by Product and Service, 2019-2032 (USD billion)
    • 9.5.5.2. China: In Vitro diagnostics quality control, by Technology, 2019-2032 (USD billion)
    • 9.5.5.3. China: In Vitro diagnostics quality control, by Manufacturer Type, 2019-2032 (USD billion)
    • 9.5.5.4. China: In Vitro diagnostics quality control, by End User, 2019-2032 (USD billion)
  • 9.5.6. In Vitro diagnostics quality control- India
    • 9.5.6.1. India: In Vitro diagnostics quality control, by Product and Service, 2019-2032 (USD billion)
    • 9.5.6.2. India: In Vitro diagnostics quality control, by Technology, 2019-2032 (USD billion)
    • 9.5.6.3. India: In Vitro diagnostics quality control, by Manufacturer Type, 2019-2032 (USD billion)
    • 9.5.6.4. India: In Vitro diagnostics quality control, by End User, 2019-2032 (USD billion)
  • 9.5.7. In Vitro diagnostics quality control- Malaysia
    • 9.5.7.1. Malaysia: In Vitro diagnostics quality control, by Product and Service, 2019-2032 (USD billion)
    • 9.5.7.2. Malaysia: In Vitro diagnostics quality control, by Technology, 2019-2032 (USD billion)
    • 9.5.7.3. Malaysia: In Vitro diagnostics quality control, by Manufacturer Type, 2019-2032 (USD billion)
    • 9.5.7.4. Malaysia: In Vitro diagnostics quality control, by End User, 2019-2032 (USD billion)
  • 9.5.8. In Vitro diagnostics quality control- Japan
    • 9.5.8.1. Japan: In Vitro diagnostics quality control, by Product and Service, 2019-2032 (USD billion)
    • 9.5.8.2. Japan: In Vitro diagnostics quality control, by Technology, 2019-2032 (USD billion)
    • 9.5.8.3. Japan: In Vitro diagnostics quality control, by Manufacturer Type, 2019-2032 (USD billion)
    • 9.5.8.4. Japan: In Vitro diagnostics quality control, by End User, 2019-2032 (USD billion)
  • 9.5.9. In Vitro diagnostics quality control- Indonesia
    • 9.5.9.1. Indonesia: In Vitro diagnostics quality control, by Product and Service, 2019-2032 (USD billion)
    • 9.5.9.2. Indonesia: In Vitro diagnostics quality control, by Technology, 2019-2032 (USD billion)
    • 9.5.9.3. Indonesia: In Vitro diagnostics quality control, by Manufacturer Type, 2019-2032 (USD billion)
    • 9.5.9.4. Indonesia: In Vitro diagnostics quality control, by End User, 2019-2032 (USD billion)
  • 9.5.10. In Vitro diagnostics quality control- South Korea
    • 9.5.10.1. South Korea: In Vitro diagnostics quality control, by Product and Service, 2019-2032 (USD billion)
    • 9.5.10.2. South Korea: In Vitro diagnostics quality control, by Technology, 2019-2032 (USD billion)
    • 9.5.10.3. South Korea: In Vitro diagnostics quality control, by Manufacturer Type, 2019-2032 (USD billion)
    • 9.5.10.4. South Korea: In Vitro diagnostics quality control, by End User, 2019-2032 (USD billion)
  • 9.5.11. In Vitro diagnostics quality control- Australia
    • 9.5.11.1. Australia: In Vitro diagnostics quality control, by Product and Service, 2019-2032 (USD billion)
    • 9.5.11.2. Australia: In Vitro diagnostics quality control, by Technology, 2019-2032 (USD billion)
    • 9.5.11.3. Australia: In Vitro diagnostics quality control, by Manufacturer Type, 2019-2032 (USD billion)
    • 9.5.11.4. Australia: In Vitro diagnostics quality control, by End User, 2019-2032 (USD billion)
  • 9.5.12. In Vitro diagnostics quality control- Rest of Asia Pacific
    • 9.5.12.1. Rest of Asia Pacific: In Vitro diagnostics quality control, by Product and Service, 2019-2032 (USD billion)
    • 9.5.12.2. Rest of Asia Pacific: In Vitro diagnostics quality control, by Technology, 2019-2032 (USD billion)
    • 9.5.12.3. Rest of Asia Pacific: In Vitro diagnostics quality control, by Manufacturer Type, 2019-2032 (USD billion)
    • 9.5.12.4. Rest of Asia Pacific: In Vitro diagnostics quality control, by End User, 2019-2032 (USD billion)
• 9.6. In Vitro diagnostics quality control- Middle East & Africa
  • 9.6.1. Middle East & Africa: In Vitro diagnostics quality control, by Product and Service, 2019-2032 (USD billion)
  • 9.6.2. Middle East & Africa: In Vitro diagnostics quality control, by Technology, 2019-2032 (USD billion)
  • 9.6.3. Middle East & Africa: In Vitro diagnostics quality control, by Manufacturer Type, 2019-2032 (USD billion)
  • 9.6.4. Middle East & Africa: In Vitro diagnostics quality control, by End User, 2019-2032 (USD billion)
  • 9.6.5. In Vitro diagnostics quality control- Saudi Arabia
    • 9.6.5.1. Saudi Arabia: In Vitro diagnostics quality control, by Product and Service, 2019-2032 (USD billion)
    • 9.6.5.2. Saudi Arabia: In Vitro diagnostics quality control, by Technology, 2019-2032 (USD billion)
    • 9.6.5.3. Saudi Arabia: In Vitro diagnostics quality control, by Manufacturer Type, 2019-2032 (USD billion)
    • 9.6.5.4. Saudi Arabia: In Vitro diagnostics quality control, by End User, 2019-2032 (USD billion)
  • 9.6.6. In Vitro diagnostics quality control- UAE
    • 9.6.6.1. UAE: In Vitro diagnostics quality control, by Product and Service, 2019-2032 (USD billion)
    • 9.6.6.2. UAE: In Vitro diagnostics quality control, by Technology, 2019-2032 (USD billion)
    • 9.6.6.3. UAE: In Vitro diagnostics quality control, by Manufacturer Type, 2019-2032 (USD billion)
    • 9.6.6.4. UAE: In Vitro diagnostics quality control, by End User, 2019-2032 (USD billion)
  • 9.6.7. In Vitro diagnostics quality control- Israel
    • 9.6.7.1. Israel: In Vitro diagnostics quality control, by Product and Service, 2019-2032 (USD billion)
    • 9.6.7.2. Israel: In Vitro diagnostics quality control, by Technology, 2019-2032 (USD billion)
    • 9.6.7.3. Israel: In Vitro diagnostics quality control, by Manufacturer Type, 2019-2032 (USD billion)
    • 9.6.7.4. Israel: In Vitro diagnostics quality control, by End User, 2019-2032 (USD billion)
  • 9.6.8. In Vitro diagnostics quality control- South Africa
    • 9.6.8.1. South Africa: In Vitro diagnostics quality control, by Product and Service, 2019-2032 (USD billion)
    • 9.6.8.2. South Africa: In Vitro diagnostics quality control, by Technology, 2019-2032 (USD billion)
    • 9.6.8.3. South Africa: In Vitro diagnostics quality control, by Manufacturer Type, 2019-2032 (USD billion)
    • 9.6.8.4. South Africa: In Vitro diagnostics quality control, by End User, 2019-2032 (USD billion)
  • 9.6.9. In Vitro diagnostics quality control- Rest of Middle East & Africa
    • 9.6.9.1. Rest of Middle East & Africa: In Vitro diagnostics quality control, by Product and Service, 2019-2032 (USD billion)
    • 9.6.9.2. Rest of Middle East & Africa: In Vitro diagnostics quality control, by Technology, 2019-2032 (USD billion)
    • 9.6.9.3. Rest of Middle East & Africa: In Vitro diagnostics quality control, by Manufacturer Type, 2019-2032 (USD billion)
    • 9.6.9.4. Rest of Middle East & Africa: In Vitro diagnostics quality control, by End User, 2019-2032 (USD billion)
• 9.7. In Vitro diagnostics quality control- Latin America
  • 9.7.1. Latin America: In Vitro diagnostics quality control, by Product and Service, 2019-2032 (USD billion)
  • 9.7.2. Latin America: In Vitro diagnostics quality control, by Technology, 2019-2032 (USD billion)
  • 9.7.3. Latin America: In Vitro diagnostics quality control, by Manufacturer Type, 2019-2032 (USD billion)
  • 9.7.4. Latin America: In Vitro diagnostics quality control, by End User, 2019-2032 (USD billion)
  • 9.7.5. In Vitro diagnostics quality control- Mexico
    • 9.7.5.1. Mexico: In Vitro diagnostics quality control, by Product and Service, 2019-2032 (USD billion)
    • 9.7.5.2. Mexico: In Vitro diagnostics quality control, by Technology, 2019-2032 (USD billion)
    • 9.7.5.3. Mexico: In Vitro diagnostics quality control, by Manufacturer Type, 2019-2032 (USD billion)
    • 9.7.5.4. Mexico: In Vitro diagnostics quality control, by End User, 2019-2032 (USD billion)
  • 9.7.6. In Vitro diagnostics quality control- Brazil
    • 9.7.6.1. Brazil: In Vitro diagnostics quality control, by Product and Service, 2019-2032 (USD billion)
    • 9.7.6.2. Brazil: In Vitro diagnostics quality control, by Technology, 2019-2032 (USD billion)
    • 9.7.6.3. Brazil: In Vitro diagnostics quality control, by Manufacturer Type, 2019-2032 (USD billion)
    • 9.7.6.4. Brazil: In Vitro diagnostics quality control, by End User, 2019-2032 (USD billion)
  • 9.7.7. In Vitro diagnostics quality control- Argentina
    • 9.7.7.1. Argentina: In Vitro diagnostics quality control, by Product and Service, 2019-2032 (USD billion)
    • 9.7.7.2. Argentina: In Vitro diagnostics quality control, by Technology, 2019-2032 (USD billion)
    • 9.7.7.3. Argentina: In Vitro diagnostics quality control, by Manufacturer Type, 2019-2032 (USD billion)
    • 9.7.7.4. Argentina: In Vitro diagnostics quality control, by End User, 2019-2032 (USD billion)
  • 9.7.8. In Vitro diagnostics quality control- Rest of Latin America
    • 9.7.8.1. Rest of Latin America: In Vitro diagnostics quality control, by Product and Service, 2019-2032 (USD billion)
    • 9.7.8.2. Rest of Latin America: In Vitro diagnostics quality control, by Technology, 2019-2032 (USD billion)
    • 9.7.8.3. Rest of Latin America: In Vitro diagnostics quality control, by Manufacturer Type, 2019-2032 (USD billion)
    • 9.7.8.4. Rest of Latin America: In Vitro diagnostics quality control, by End User, 2019-2032 (USD billion)

10. Competitive Landscape

• 10.1. Expansion and Acquisition Analysis
  • 10.1.1. Expansion
  • 10.1.2. Acquisitions
• 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

• 11.1. Abbott Laboratories
  • 11.1.1. Company Overview
  • 11.1.2. Financial Performance
  • 11.1.3. Product Benchmarking
  • 11.1.4. Recent Development
• 11.2. Alpha-Tec Systems
  • 11.2.1. Company Overview
  • 11.2.2. Financial Performance
  • 11.2.3. Product Benchmarking
  • 11.2.4. Recent Development
• 11.3. BIO-RAD LABORATORIES, INC.
  • 11.3.1. Company Overview
  • 11.3.2. Financial Performance
  • 11.3.3. Product Benchmarking
  • 11.3.4. Recent Development
• 11.4. Bio-Techne Corporation
  • 11.4.1. Company Overview
  • 11.4.2. Financial Performance
  • 11.4.3. Product Benchmarking
  • 11.4.4. Recent Development
• 11.5. CleanNA
  • 11.5.1. Company Overview
  • 11.5.2. Financial Performance
  • 11.5.3. Product Benchmarking
  • 11.5.4. Recent Development
• 11.6. DANAHER CORPORATION
  • 11.6.1. Company Overview
  • 11.6.2. Financial Performance
  • 11.6.3. Product Benchmarking
  • 11.6.4. Recent Development
• 11.7. Fortress Diagnostics
  • 11.7.1. Company Overview
  • 11.7.2. Financial Performance
  • 11.7.3. Product Benchmarking
  • 11.7.4. Recent Development
• 11.8. Newland EMEA
  • 11.8.1. Company Overview
  • 11.8.2. Financial Performance
  • 11.8.3. Product Benchmarking
  • 11.8.4. Recent Development
• 11.9. Helena Laboratories Corporation
  • 11.9.1. Company Overview
  • 11.9.2. Financial Performance
  • 11.9.3. Product Benchmarking
  • 11.9.4. Recent Development
• 11.10. Grifols, S.A.
  • 11.10.1. Company Overview
  • 11.10.2. Financial Performance
  • 11.10.3. Product Benchmarking
  • 11.10.4. Recent Development
• 11.11. Maine Molecular Quality Controls, Inc.
  • 11.11.1. Company Overview
  • 11.11.2. Financial Performance
  • 11.11.3. Product Benchmarking
  • 11.11.4. Recent Development
• 11.12. Microbiologics
  • 11.12.1. Company Overview
  • 11.12.2. Financial Performance
  • 11.12.3. Product Benchmarking
  • 11.12.4. Recent Development
• 11.13. Microbix Biosystems
  • 11.13.1. Company Overview
  • 11.13.2. Financial Performance
  • 11.13.3. Product Benchmarking
  • 11.13.4. Recent Development
• 11.14. Ortho-Clinical Diagnostics
  • 11.14.1. Company Overview
  • 11.14.2. Financial Performance
  • 11.14.3. Product Benchmarking
  • 11.14.4. Recent Development